Immunoluminometric assay for quantification of peroxiredoxin 4 in human serum

Clinica Chimica Acta

Volumn 411, Issue 17-18, 2010, Pages 1258-1263

  Schulte, Janin ^a   Struck, Joachim ^a   Bergmann, Andreas ^a   Köhrle, Josef ^b  

^a THERMO FISHER SCIENTIFIC   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Oxidative stress; Peroxiredoxin; Sandwich immunoassay; Serum

Indexed keywords

PEROXIREDOXIN 4; PROCALCITONIN; PEROXIREDOXIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE MARKER; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE STUDY; SANDWICH IMMUNOLUMINOMETRIC ASSAY; SENSITIVITY ANALYSIS; SEPSIS; AMINO ACID SEQUENCE; BLOOD; CASE CONTROL STUDY; CHEMISTRY; GEL CHROMATOGRAPHY; MOLECULAR GENETICS; PROCEDURES; REPRODUCIBILITY; SEQUENCE HOMOLOGY; STANDARD; STANDARDS;

AMINO ACID SEQUENCE; CASE-CONTROL STUDIES; CHROMATOGRAPHY, GEL; HUMANS; IMMUNOASSAY; MOLECULAR SEQUENCE DATA; PEROXIREDOXINS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SEPSIS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 77954144349     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.05.016     Document Type: Article

References (25)

1. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006, 52:601-623.
2. Giustarini D., Dalle-Donne I., Tsikas D., Rossi R. Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci 2009, 46:241-281.
3. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84.
4. Fujii J., Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 2002, 7:123-130.
5. Wood Z.A., Schröder E., Harris J.R., Poole L.B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 2003, 28:32-40.
6. Ellis H.R., Poole L.B. Roles for the two cysteine residues of AhpC in catalysis of peroxide reduction by alkyl hydroperoxide reductase from Salmonella typhimurium. Biochemistry 1997, 36:13349-13356.
7. Hirotsu S., Abe Y., Okada K., et al. Crystal structure of a multifunctional 2-Cys peroxiredoxin heme-binding protein 23kDa/proliferation-associated gene product. Proc Natl Acad Sci USA 1999, 96:12333-12338.
8. Rabilloud T., Heller M., Gasnier F., et al. Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J Biol Chem 2002, 277:19396-19401.
9. Wagner E., Luche S., Penna L., et al. A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress. Biochem J 2002, 366:777-785.
10. Matsumoto A., Okado A., Fujii T., et al. Cloning of the peroxiredoxin gene family in rats and characterization of the fourth member. FEBS Lett 1999, 443:246-250.
11. Okado-Matsumoto A., Matsumoto A., Fujii J., Taniguchi N. Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J Biochem 2000, 127:493-501.
12. Tavender T.J., Sheppard A.M., Bulleid N.J. Peroxiredoxin IV is an endoplasmic reticulum-localized enzyme forming oligomeric complexes in human cells. Biochem J 2008, 411:191-199.
13. Haridas V., Ni J., Meager A., et al. TRANK, a novel cytokine that activates NF-kappa B and c-Jun N-terminal kinase. J Immunol 1998, 161:1-6.
14. Jin D.-Y., Chae H.Z., Rhee S.G., Jeang K.-T. Regulatory role for a novel human thioredoxin peroxidase in NF-κB activation. J Biol Chem 1997, 272:30952-30961.
15. Chang X., Cui Y., Zong M., et al. Identification of proteins with increased expression in rheumatoid arthritis synovial tissues. J Rheumatol 2009, 36:872-880.
16. Jones D.P. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 2008, 295:C849-C868.
17. Struck J., Strebelow M., Tietz S. Method for the selective measurement of amino-terminal variants of procalcitonin. Clin Chem 2009.
18. Papassotiriou J., Morgenthaler N.G., Struck J., Alonso C., Bergmann A. Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma. Clin Chem 2006, 52:1144-1151.
19. Lee W., Choi K.S., Riddell J., et al. Human peroxiredoxin 1 and 2 are not duplicate proteins: the unique presence of CYS83 in Prx1 underscores the structural and functional differences between Prx1 and Prx2. J Biol Chem 2007, 282:22011-22022.
20. Schröder E., Littlechild J.A., Lebedev A.A., Errington N., Vagin A.A., Isupov M.N. Crystal structure of decameric 2-Cys peroxiredoxin from human erythrocytes at 1.7 Å resolution. Structure 2000, 8:605-615.
21. Victor V.M., Rocha M., Esplugues J.V., De la Fuente M. Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 2005, 11:3141-3158.
22. Hofer S., Rosenhagen C., Nakamura H., et al. Thioredoxin in human and experimental sepsis. Crit Care Med 2009, 37:2155-2159.
23. Warner A., Bencosme A., Healy D., Verme C. Prognostic role of antioxidant enzymes in sepsis: preliminary assessment. Clin Chem 1995, 41:867-871.
24. Carrol E.D., Thomson A.P., Hart C.A. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 2002, 20:1-9.
25. Meisner M. Biomarkers of sepsis: clinically useful?. Curr Opin Crit Care 2005, 11:473-480.